ERBITUX 5MG INFUSION is a Schedule H drug. ERBITUX 5MG INFUSION is composed of: CETUXIMAB (5.0 MG)
Tag: medicine for head and neck cancer
ERBITUX 500MG INFUSION
ERBITUX 500MG INFUSION is a Schedule H drug. ERBITUX 500MG INFUSION is composed of: CETUXIMAB (500.0 MG)
ERBITUX 100MG INFUSION
ERBITUX 100MG INFUSION is a Schedule H drug. ERBITUX 100MG INFUSION is composed of: CETUXIMAB (100.0 MG)
NIVOLUMAB
NIVOLUMAB is a Schedule H drug.
CETUXIMAB
CETUXIMAB is a Schedule H drug.